
    
      A Phase 3, Multi-Center, Double-Masked, Vehicle Controlled, Randomized, Parallel-Group Study
      to Assess Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group for the
      Treatment of Ocular Inflammation and Pain Following Cataract Surgery.
    
  